📰 Alacyclovir News
Page 13 - Alacyclovir News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alacyclovir. Real-time updates on events, politics, business and more.
March 2, 2022
Along with the roadmap presented by President Biden in his State of the Union, there are plans for better surveillance for new variants, faster vaccine development, and more focus on Long COVID.
March 1, 2022
The American College of Physicians has issued its fifth and final update of their living, rapid review on use of remdesivir in hospitalized patients with COVID-19.
February 25, 2022
"Compared to 2 years ago, yes, we have more tools in our toolkit, which is great. But we still have to find the right drugs [for the right patient]."
February 18, 2022
Early antiviral treatment of influenza reduces mortality risk in CAP patients but in-hospital testing is not happening often enough to initiate treatment.
February 17, 2022
Stay current on FDA drug approvals in 2022
February 9, 2022
Physicians have highly varied views on whether its the right time to drop masks or whether doing so would set the nation back.
February 4, 2022
In June, the US government agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and in November agreed to buy an additional 1.4 billion courses for $1 billion.
February 2, 2022
The COVID-19 drug remdesivir last year overtook AbbVies 20-year-old arthritis drug Humira as the medicine that US hospitals spent the most on.
February 2, 2022
Residents can receive same-day deliveries of the Pfizer product Paxlovid or the Merck product molnupiravir while supplies last.
January 28, 2022
The European Unions drug regulator on Thursday gave the green light to Pfizer Incs antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant.